These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6422755)

  • 1. Laboratory evaluation of factor VIII and factor IX.
    Baglini RL
    Am J Med Technol; 1983 Dec; 49(12):857-62. PubMed ID: 6422755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ; McRoyan DK; Liu PI
    Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry.
    Chen D; Daigh CA; Hendricksen JI; Pruthi RK; Nichols WL; Heit JA; Owen WG
    J Thromb Haemost; 2008 Feb; 6(2):323-30. PubMed ID: 18031294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
    Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New methods in coagulation.
    Triplett DA
    Crit Rev Clin Lab Sci; 1981; 15(1):25-84. PubMed ID: 6459909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory diagnosis of von Willebrand's disease in 52 patients].
    Mezzano D; Aranda E; Grebe G; Legues ME; Rodríguez S; Marzouka E; Ríos E
    Rev Med Chil; 1983 Nov; 111(11):1139-44. PubMed ID: 6431575
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired Von Willebrand disease in children with a Wilms' tumor.
    Jonge Poerink-Stockschlader AB; Dekker I; Risseeuw-Appel IM; Hählen K
    Med Pediatr Oncol; 1996 Apr; 26(4):238-43. PubMed ID: 8600334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U; Drewke E; Mainusch K; Schneppenheim R
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM anticoagulant with acquired abnormalities in factor VIII.
    Andes WA
    Thromb Res; 1982 Sep; 27(6):703-12. PubMed ID: 6817451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand disease: a laboratory approach.
    Trasi S; Ghosh K; Shetty S; Mohanty D
    Natl Med J India; 2005; 18(2):78-84. PubMed ID: 15981443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA; Ludwig G; Scharrer I
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.